SCHEMBL4454930

SCHEMBL4454930

CCCCN=Cc1ccc2c(c1)OCO2

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.62
KDM4E B2RXH2 2/20 0.62
ALOX15 P16050 1/20 0.62
MAPT P10636 3/20 0.53
PIM1 P11309 2/20 0.50
CDK5 Q00535 2/20 0.50
CDK5R1 Q15078 2/20 0.50
DYRK2 Q92630 2/20 0.50
GSK3A P49840 2/20 0.49
GSK3B P49841 2/20 0.49
CYP3A4 P08684 3/20 0.49
ATM Q13315 1/20 0.49
CYP1A2 P05177 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4454927 1.00 ALDH1A1 (0.62) ALDH1A1KDM4EALOX15MAPTPIM1
SCHEMBL16704292 0.91 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15MAPTPIM1
SCHEMBL3031855 0.91 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15MAPTPIM1
SCHEMBL5452087 0.85 ALDH1A1 (0.62) ALDH1A1KDM4EALOX15MAPTGSK3A
SCHEMBL14627221 0.85 ALDH1A1 (0.62) ALDH1A1KDM4EALOX15MAPTGSK3A
SCHEMBL11558191 0.84 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15MAPTGSK3A
SCHEMBL11558188 0.84 ALDH1A1 (0.58) ALDH1A1KDM4EALOX15MAPTGSK3A
SCHEMBL4449592 0.84 CYP3A4 (0.54) ALDH1A1KDM4EALOX15MAPTPIM1
SCHEMBL4449591 0.84 CYP3A4 (0.54) ALDH1A1KDM4EALOX15MAPTPIM1
SCHEMBL16168568 0.79 ALDH1A1 (0.55) ALDH1A1KDM4EALOX15MAPTGSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2050452-A1 indenoisoquinolines as topoisomerase inhibitors I useful as antineoplastic agents Purdue Research Foundation (US) 2009-04-22 EP disclosed
US-6509344-B1 A method for treating a patient having cancer, said method comprising the step of administering to the patient an effective amount of a compound according to claim 1, whereupon said patient is treated for cancer, and wherein the cancer is THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2003-01-21 US disclosed
EP-1123099-A4 NOVEL INDENOISOQUINOLINES AS ANTINEOPLASTIC AGENTS PURDUE RESEARCH FOUNDATION (US) 2002-08-21 EP disclosed
EP-1123099-A1 NOVEL INDENOISOQUINOLINES AS ANTINEOPLASTIC AGENTS PURDUE RESEARCH FOUNDATION (US) 2001-08-16 EP disclosed
WO-2000021537-A1 NOVEL INDENOISOQUINOLINES AS ANTINEOPLASTIC AGENTS PURDUE RESEARCH FOUNDATION (US) 2000-04-20 WO disclosed
EP-0190105-A2 Herbicidal agent CIBA-GEIGY AG (CH) 1986-08-06 EP disclosed